Literature DB >> 24915207

A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.

Debby Ben-David1, Samira Masarwa, Amos Adler, Hagit Mishali, Yehuda Carmeli, Mitchell J Schwaber.   

Abstract

OBJECTIVE: Patients hospitalized in post-acute care hospitals (PACHs) constitute an important reservoir of antimicrobial-resistant bacteria. High carriage prevalence of carbapenem-resistant Enterobacteriaceae (CRE) has been observed among patients hospitalized in PACHs. The objective of the study is to describe the impact of a national infection control intervention on the prevalence of CRE in PACHs.
DESIGN: A prospective cohort interventional study.
SETTING: Thirteen PACHs in Israel. INTERVENTION: A multifaceted intervention was initiated between 2008 and 2011 as part of a national program involving all Israeli healthcare facilities. The intervention has included (1) periodic on-site assessments of infection control policies and resources, using a score comprised of 16 elements; (2) assessment of risk factors for CRE colonization; (3) development of national guidelines for CRE control in PACHs involving active surveillance and contact isolation of carriers; and (4) 3 cross-sectional surveys of rectal carriage of CRE that were conducted in representative wards.
RESULTS: The infection control score increased from 6.8 to 14.0 (P < .001) over the course of the study period. A total of 3,516 patients were screened in the 3 surveys. Prevalence of carriage among those not known to be carriers decreased from 12.1% to 7.9% (P = .008). Overall carrier prevalence decreased from 16.8% to 12.5% (P = .013). Availability of alcohol-based hand rub, appropriate use of gloves, and a policy of CRE surveillance at admission to the hospital were independently associated with lower new carrier prevalence.
CONCLUSION: A nationwide infection control intervention was associated with enhanced infection control measures and a reduction in the prevalence of CRE in PACHs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24915207     DOI: 10.1086/676876

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  15 in total

1.  Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.

Authors:  L Lapointe-Shaw; T Voruganti; P Kohler; H-H Thein; B Sander; A McGeer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-11       Impact factor: 3.267

Review 2.  Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.

Authors:  Olivia Smibert; Michael J Satlin; Anoma Nellore; Anton Y Peleg
Journal:  Curr Infect Dis Rep       Date:  2019-06-10       Impact factor: 3.725

3.  Reducing dissemination of carbapenem-resistant Klebsiella pneumoniae.

Authors:  Matteo Bassetti; Daniele Roberto Giacobbe
Journal:  Ann Transl Med       Date:  2019-12

4.  Multidrug-Resistant Gram-Negative Bacteria: Inter- and Intradissemination Among Nursing Homes of Residents With Advanced Dementia.

Authors:  Erika M C D'Agata; Daniel Habtemariam; Susan Mitchell
Journal:  Infect Control Hosp Epidemiol       Date:  2015-04-29       Impact factor: 3.254

5.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 6.  The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria.

Authors:  Federico Perez; Maria Virginia Villegas
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

7.  Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.

Authors:  D Lepelletier; J C Lucet; P Astagneau; B Coignard; S Vaux; C Rabaud; B Grandbastien; P Berthelot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-10       Impact factor: 3.267

Review 8.  Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.

Authors:  Hsin-Yu Chen; Shio-Shin Jean; Yu-Lin Lee; Min-Chi Lu; Wen-Chien Ko; Po-Yu Liu; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

9.  Trends in antimicrobial resistance in Israel, 2014-2017.

Authors:  Yaakov Dickstein; Elizabeth Temkin; Michal Ish Shalom; David Schwartz; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-04       Impact factor: 4.887

10.  Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable.

Authors:  Jordana K Schmier; Carolyn K Hulme-Lowe; Svetlana Semenova; Juergen A Klenk; Paul C DeLeo; Richard Sedlak; Pete A Carlson
Journal:  Clinicoecon Outcomes Res       Date:  2016-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.